AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
20.31
+0.34 (1.70%)
Nov 20, 2024, 4:00 PM EST - Market closed
AnaptysBio Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 54.64, with a low estimate of 30 and a high estimate of 90. The average target predicts an increase of 169.03% from the current stock price of 20.31.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $75 → $66 | Buy | Maintains | $75 → $66 | +224.96% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $55 → $52 | Strong Buy | Maintains | $55 → $52 | +156.03% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +170.80% | Oct 31, 2024 |
| UBS | UBS | Hold Maintains $23 → $33 | Hold | Maintains | $23 → $33 | +62.48% | Oct 30, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $75 → $90 | Strong Buy | Maintains | $75 → $90 | +343.13% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
52.76M
from 17.16M
Increased by 207.49%
Revenue Next Year
37.58M
from 52.76M
Decreased by -28.77%
EPS This Year
-6.26
from -6.08
EPS Next Year
-6.57
from -6.26
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 67.4M | 74.4M | 120.7M | ||
| Avg | 52.8M | 37.6M | 49.3M | ||
| Low | 32.5M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 292.9% | 41.0% | 221.2% | ||
| Avg | 207.5% | -28.8% | 31.2% | ||
| Low | 89.4% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.48 | -2.36 | -2.50 | ||
| Avg | -6.26 | -6.57 | -6.04 | ||
| Low | -6.76 | -8.03 | -10.26 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.